Micro Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OLMESARTAN MEDOXOMIL USP, with a corresponding US DMF Number 27539.
Remarkably, this DMF maintains an Active status since its submission on September 26, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 26, 2014, and payment made on September 26, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II